patients from the International Myeloma Working Group favorable features and shows better survival: an analysis of 10 549 Myeloma in patients younger than age 50 years presents with more

Michèle Cavo; Philip R. Greipp; Douglas Joshua; Michel Attal; Pieter Sonneveld; John Crowley; Meral Beksaç; Mario Boccadoro; Antonio Palumbo; Bart Barlogie; Chaim Shustik; Rafaël Fonseca; Meletios A Dimopoulos; Kazuyuki Shimizu; Jesús F. San Miguel; Jan Westin; Jean-Luc Heinz Ludwig; Brian G.M. Durie; Vanessa Bolejack; Ingemar Turesson; Robert A. Kyle; Joan Bladé

Article2008

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group

Heinz Ludwig, Brian G.M. Durie, Vanessa Bolejack, Ingemar Turesson, Robert A. Kyle, Joan Bladé, Rafaël Fonseca, Meletios A Dimopoulos, Kazuyuki Shimizu, Jesús F. San Miguel, Jan Westin, Jean‐Luc Harousseau, Meral Beksaç, Mario Boccadoro, Antonio Palumbo, Bart Barlogie, Chaim Shustik, Michèle Cavo, Philip R. Greipp, Douglas Joshua, Michel Attal, Pieter Sonneveld, John Crowley

Article2015

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

Antonio Palumbo, Sara Bringhen, María‐Victoria Mateos, Alessandra Larocca, Thierry Façon, Shaji Kumar, Massimo Offidani, Philip L. McCarthy, Andrea Evangelista, Sagar Lonial, Sonja Zweegman, Pellegrino Musto, Evangelos Terpos, Andrew Belch, Roman Hájek, Heinz Ludwig, A. Keith Stewart, Philippe Moreau, Kenneth C. Anderson, Hermann Einsele, Brian G.M. Durie, Meletios A Dimopoulos, ,

Article2025

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group

Despina Fotiou, Sorina Bădeliță, Eirini Katodritou, Meral Beksaç, Jelena Bila, Emmanouil Spanoudakis, Josip Batinić, Daniel Coriu, Sinziana Barbu, Catalin Danaı̈la, Dimitra Dalampira, Angeliki Sevastoudi, Güldane Cengiz Seval, Selami Koçak Toprak, Aleksandra Sretenović, Olivera Marković, Toni Valković, Zorica Cvetković, Fenia Theodorakakou, Maria Gavriatopoulou, Evangelos Terpos, Meletios A Dimopoulos,

Article2023

P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP

Efstathios Kastritis, Meral Beksaç, Sorina Bădeliță, Eirini Katodritou, Jelena Bila, Emmanouil Spanoudakis, Güldane Cengiz Seval, Zorica Cvetković, Daniel Coriu, Milena Mitrović, Carmen Șaguna, Dimitra Dalampira, Anca Bojan, Josip Batinić, Samo Zver, Margarita Guenova, Arben Ivanaj, Maria Gavriatopoulou, Evangelos Terpos, Meletios A Dimopoulos

Article2019

Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study

Shaji Kumar, Jin Lu, Yang Terry Liu, Max Bittrich, Juan Du, Hartmut Goldschmidt, Charalampia Kyriakou, Donna Reece, Kihyun Kım, María‐Victoria Mateos, Verónica González‐Calle, Wen-Ming Chen, Heinz Ludwig, Giampaolo Merlini, Silvia Mangiacavalli, Meletios A Dimopoulos, Eftathios Kastritis, Chang‐Ki Min, Graça Esteves, Andrew J. Yee, Noopur Raje, Emily Rosta, Anja Haltner,

patients from the International Myeloma Working Group favorable features and shows better survival: an analysis of 10 549 Myeloma in patients younger than age 50 years presents with more

Abstract

Discussion(0)

Related publications

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group

P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP

Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study

patients from the International Myeloma Working Group favorable features and shows better survival: an analysis of 10 549 Myeloma in patients younger than age 50 years presents with more

Abstract

Discussion(0)

Related publications

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group

P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS &lt;50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP

Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study

P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP